Nichd: r & d: best pharmaceuticals for children act (bpca) pediatric trials network (PTN): core function activities - the contractor shall establish and maintain centralized teams of experts who…
Active Awarded Last action
- Contract number
- 75N94025F00001
- Awardee
-
Duke University UEI TP7EK8DZV6N5
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,790,048
Award facts
- Opportunity
-
- Best Pharmaceuticals for Children Act (BPCA) Pediatric Trials Network (PTN) Pre-Solicitation · 75N94024R00008 · Posted Jan 3, 2024
- Contract value 28% obligated
-
- $4,790,048.00 Current, with exercised options
- $17,176,043.00 Potential, with all options
- Completion date 20% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Durham, NC 27705, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $2,370,820 | |
| Supplemental Agreement for work within scope | $279,641 | |
| Original award | $1,919,815 |
About this award
The National Institute of Child Health and Human Development (NICHD) issued a delivery order to Duke University on June 4, 2025, under the Best Pharmaceuticals for Children Act (BPCA) Pediatric Trials Network (PTN) IDIQ with a ceiling value of $17.2 million.
The BPCA Pediatric Trials Network is a research and development IDIQ supporting establishment and maintenance of centralized expert teams to develop protocols, informed consent forms, and core function activities for pediatric drug trials. Place of performance is Durham, NC. The order is severable and runs through June 3, 2032, on a cost-no-fee basis. This delivery order funds core function activities within the broader PTN program, which advances pediatric therapeutics through federal investment in clinical trial infrastructure and protocol development.
Description
Nichd: r & d: best pharmaceuticals for children act (bpca) pediatric trials network (PTN): core function activities - the contractor shall establish and maintain centralized teams of experts who will develop protocols and informed consent forms and
Quick answers
Who was awarded contract 75N94025F00001?
75N94025F00001 was awarded to Duke University by National Institute of Child Health and Human Development (National Institutes of Health) on June 4, 2025.
How much is contract 75N94025F00001 worth?
The government has obligated $4,790,048 on 75N94025F00001. Its potential value, with all options, is $17,176,043.
Is contract 75N94025F00001 an order under another contract?
Yes. 75N94025F00001 is a delivery order under 75N94025D00003, an indefinite delivery contract.
Was contract 75N94025F00001 competed?
The extent of competition for 75N94025F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award